Read now on PRNewswire.com • October 2, 2018
Category: BIOMEDICAL
Saladax Biomedical welcomes new guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil therapy
Read now on BusinessWire.com • September 19, 2018
Saladax Biomedical submits antipsychotic drug test for FDA review
Read now on 360dx.com • July 17, 2018
State’s 100 Best Companies to Work For announced
Read now on VBJUSA.com • July 13, 2018
Bethlehem biotech company to acquire exclusive patent rights to antipsychotic drug tests
Read now on LVB.com • June 28, 2018
Bethlehem biotech company Saladax signs licensing deal with Johnson & Johnson affiliate
Read now on MCall.com • June 28, 2018
Saladax signs licensing agreement with Janssen for antipsychotic drug testing patents
Read now on BusinessWire.com • June 26, 2018
AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech
Read now on BioPharma-Reporter.com • June 20, 2018
AbSci raises oversubscribed $12M Series C to fuel commercialization of its groundbreaking protein expression platform
Read now on AbSci.com • May 30, 2018
Vancouver-based AbSci raises $12 million for research product
Read now on Columbian.com • May 30, 2018
Columbia Ventures Corporation 